These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9700703)

  • 1. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis.
    De Keyser J; Zwanikken C; Boon M
    J Neurol Sci; 1998 Jul; 159(1):51-3. PubMed ID: 9700703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination in patients with multiple sclerosis.
    Sibley WA; Bamford CR; Laguna JF
    JAMA; 1976 Oct; 236(17):1965-6. PubMed ID: 989559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal and H1N1v influenza vaccines in MS: safety and compliance.
    Auriel E; Gadoth A; Regev K; Karni A
    J Neurol Sci; 2012 Mar; 314(1-2):102-3. PubMed ID: 22056469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza vaccination in multiple sclerosis.
    Sibley WA; Bamford CR; Laguna JF
    JAMA; 1976 Oct; 236(17):1935. PubMed ID: 989548
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group.
    Confavreux C; Suissa S; Saddier P; Bourdès V; Vukusic S;
    N Engl J Med; 2001 Feb; 344(5):319-26. PubMed ID: 11172162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.
    Farez MF; Ysrraelit MC; Fiol M; Correale J
    Mult Scler; 2012 Feb; 18(2):254-6. PubMed ID: 21828198
    [No Abstract]   [Full Text] [Related]  

  • 7. Swine-influenza vaccination in multiple sclerosis.
    Myers LW; Ellison GW; Lucia M; Novom S
    N Engl J Med; 1976 Nov; 295(21):1204. PubMed ID: 790182
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic factors in multiple sclerosis: role of intercurrent infections and vaccinations against influenza and hepatitis B.
    Merelli E; Casoni F
    Neurol Sci; 2000; 21(4 Suppl 2):S853-6. PubMed ID: 11205362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination.
    Salvetti M; Pisani A; Bastianello S; Millefiorini E; Buttinelli C; Pozzilli C
    J Neurol; 1995 Feb; 242(3):143-6. PubMed ID: 7751856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
    Liao Z; Tang H; Xu X; Liang Y; Xiong Y; Ni J
    PLoS One; 2016; 11(2):e0147856. PubMed ID: 26845680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial magnetic resonance imaging studies with paramagnetic contrast medium: assessment of disease activity in patients with multiple sclerosis before and after influenza vaccination.
    Michielsens B; Wilms G; Marchal G; Carton H
    Eur Neurol; 1990; 30(5):258-9. PubMed ID: 2269314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerability of 2 doses of pandemic influenza vaccine (Focetria®) and of a prior dose of seasonal 2009-2010 influenza vaccination in the Netherlands.
    van der Maas NA; Godefrooij S; Vermeer-de Bondt PE; de Melker HE; Kemmeren J
    Hum Vaccin Immunother; 2016 Apr; 12(4):1027-32. PubMed ID: 26809939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression during exacerbations in multiple sclerosis: the importance of uncertainty.
    Kroencke DC; Denney DR; Lynch SG
    Mult Scler; 2001 Aug; 7(4):237-42. PubMed ID: 11548983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the risk of severe outcomes and the role of seasonal influenza vaccination in pregnant women hospitalized with confirmed influenza, Spain, 2010/11-2015/16.
    Mazagatos C; Delgado-Sanz C; Oliva J; Gherasim A; Larrauri A;
    PLoS One; 2018; 13(8):e0200934. PubMed ID: 30089148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of influenza vaccination on the incidence of chronic obstructive pulmonary disease exacerbations in the immediate postvaccination period.
    Ting SC; Crooks SW; South G
    J Epidemiol Community Health; 2011 Feb; 65(2):157-9. PubMed ID: 19996358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adverse events following influenza vaccination: reaction to specific reports and the necessity of a central registration system].
    Swaan CM; van der Sande MA; Speelman P; Conyn-van Spaendonck MA; Straus SM; Coutinho RA
    Ned Tijdschr Geneeskd; 2007 Sep; 151(39):2166-9. PubMed ID: 17957995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
    Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different collection methods for reported adverse events following pandemic and seasonal influenza vaccination.
    Kemmeren J; Honsbeek M; Dijkstra F; de Lange M; van der Maas N; Smallenburg R; Koppeschaar C; van der Hoek W
    Vaccine; 2016 Jul; 34(34):3961-6. PubMed ID: 27349839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence risk of oculorespiratory syndrome after influenza vaccination: randomized controlled trial of previously affected persons.
    De Serres G; Skowronski DM; Guay M; Rochette L; Jacobsen K; Fuller T; Duval B
    Arch Intern Med; 2004 Nov; 164(20):2266-72. PubMed ID: 15534165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting Influenza Vaccination Exemption.
    Ryan M; Duran L; Lee R; Wu S
    Emerg Infect Dis; 2018 Oct; 24(10):1947-1948. PubMed ID: 30226178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.